CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Curbside Consults: Top Questions from PCPs on Menopause and Arthritis
Jan L. Shifren, MD | Peng Thim Fan, MD, FACP
What do primary care providers need to know about menopause and arthritis? Join expert faculty as they review important questions they get asked about these topics!
Director, Midlife Women’s Health Center, Massachusetts General Hospital, Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA
Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
Challenging Cases in Primary Care
Pamela Kushner, MD, FAAFP
In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.
Clinical Professor, University of California Irvine Medical Center Director, Kushner Wellness Center, Los Alamitos, CA
David Wolinsky, MD, FACC, MASNC
This Product Theater Presentation focuses on providing education to Frontline Providers on the topics of CAD risk assessment, the various testing modalities available, the value of SPECT MPI, and the Appropriate Use Criteria (AUC).
Head of Nuclear Cardiology, Cleveland Clinic, Florida
Sponsored by Astellas Pharma U.S., Inc.
COPD: New for 22
Corinne R. Young, MSN, FNP-C, FCCP | Justin Hovey, M.D., FAAP
This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.
Nurse Practitioner, Director of APP and Clinical Services, Study Coordinator, Colorado Springs Pulmonary Consultants, PC
President, Internal Medicine and Pediatric Consultants, P.C.
Sponsored by GlaxoSmithKline
Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..
Cardiometabolic Panel Discussion: Making Sense of New Guideline Updates
Archana R. Sadhu, MD, FACE | Ty J. Gluckman, MD, FACC, FAHA
Do you want to provide the most up-to-date, evidence-based care for your patients with cardiometabolic disease? Then you won’t want to miss this session that provides an overview of updated clinical practice guidelines for the treatment of hypertriglyceridemia and type 2 diabetes followed by an opportunity to have all your questions answered!
Director, System Diabetes Program at Houston Methodist,, Assistant Clinical Professor, Weill Cornell Medical College, Adjunct Assistant Professor, Texas A&M Health Sciences
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE
Justin Trivax, MD, FACC, FSCAI
This lecture will discuss the Treatment and reduction in the risk of recurrent DVT/PE, whether initiated in the inpatient or outpatient setting.
Millennium Cardiology, A Division of Michigan Healthcare Professionals , Clinical Faculty, Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak , Assistant Professor, Oakland University William Beaumont School of Medicine , Clinical Assistant Professor, Wayne State University School of Medicine, Co-Founder, Hearts for Heroes
Sponsored by Janssen Pharmaceuticals, Inc.
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Christopher Parker, DO
Sponsored by AbbVie Inc.
COVID-19 Panel Discussion (February 2022)
Daniel A. Solomon, MD | Laila Woc-Colburn, MD
This pandemic requires communication among specialists and primary care clinicians. In this COVID-19 panel, expert faculty will team up to discuss the most pressing and frequently asked questions about the disease and its complications.
Associate Physician, Division of Infectious Diseases
Brigham and Women's Hospital
Instructor of Medicine,
Harvard Medical School
Boston, MA
Associate Professor, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA
Curbside Consults: Top Questions from PCPs on Care of the Patient with Cellulitis and Chest Pain
Howard Libman, MD | Ty J. Gluckman, MD, FACC, FAHA
What do primary care providers need to know about cellulitis care and chest pain? Join expert faculty as they review important questions they get asked about these topics!
Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Jeff Unger, MD, FAAFP, FACE
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
Diplomate, American Board of Family Practice, Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine, Riverside, California, Director, Unger Concierge Primary Care Medical Group, Rancho Cucamonga, California
Sponsored by Novo Nordisk
Strategies for Effective Pain Management in Clinical Practice
Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Supported by Opioid Analgesic REMS Program Companies
What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration
Richard S. Isaacson, MD | Charles Vega, MD, FAAFP
Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.
This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.
Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Supported by Eisai
Spotting Sjögren’s: Keys to Successful Diagnosis for PCPs
Donald E. Thomas, MD
Sjögren’s disease (SjD) is one of the most prevalent, yet underdiagnosed autoimmune diseases. Most patients see numerous physicians in many different specialties and over months to years after symptoms first appear prior to getting an accurate diagnosis. Many are misdiagnosed with other disorders during this journey. Most patients with SjD present to their primary care provider (PCP) prior to seeing specialists, such as rheumatologists. PCPs could screen for and diagnose patients with SjD at a higher rate and expedite the time to an accurate diagnosis and hence provide much needed and effective treatments that can greatly improve their quality of life. Extraglandular complications affect most patients, proving that SjD is much more than “dry eyes and dry mouth.” PCPs are in a prime position to help identify patients with these complications and assist with proper management and referrals to the appropriate specialists. The participant in this PrimaryCareNOW course will learn the most up to date information about SjD, its diagnosis, and its treatment options. The participant will also have the opportunity to have a Q&A session with Dr. Thomas.
Chair, National Board of Directors
of the Sjogren's Foundation
The Impact and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients
Jennifer Soung, MD, FAAD
Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them.
Director of Clinical Research, Southern California Dermatology, Santa Ana, California
Sponsored by Regeneron and Sanofi Genzyme
Psychopharmacology: Prescribing with Confidence
Jeffrey Rado, MD, MPH, FAPA
What do primary care providers need to know about psychopharmacology to treat major depressive disorder and anxiety? Join Dr. Jeffrey Rado as he reviews important concepts that can help you improve the care of your patients.
Associate Professor, Northwestern Feinberg School of Medicine, Chicago, IL
Addressing Elevated Risk for Thrombotic CV Events in Patients Across the CAD Spectrum
Victor Howard, MD, FACC
AstraZeneca Pharmaceuticals, LP
Sponsored by AstraZeneca Pharmaceuticals, LP
Challenging Diagnostic Dilemmas in Primary Care
Howard Libman, MD
In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.
Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA
Bridging the Gap: Strategies for Ending the HIV Epidemic
Demetre C. Daskalakis, MD, MPH | Gregory L. Hall, MD
As part of its partnership with the Centers for Disease Control and Prevention’s Let’s Stop HIV Together campaign, Dr. Demetre Daskalakis, Director of the Division of HIV Prevention, will join Pri-Med faculty Dr. Greg Hall, expert in African American health and healthcare, as they discuss strategies for stopping the HIV epidemic across all communities. In this session, you’ll explore the concept of HIV as a syndemic and how that framework can help you identify patients with risk factors for HIV. You’ll also learn the importance of applying a status neutral approach to HIV care to ensure effective treatment and prevention of HIV across all patient populations. You’ll also leave the session with information on the latest guidelines and recommendations, including the newly released guidelines on HIV prevention with PrEP. It’s a can’t-miss educational opportunity for anyone looking for practical tools to help your patients and help end the HIV epidemic.
Director, Division of HIV/AIDS Prevention (DHAP), Centers for Disease Control and Prevention , Atlanta, GA
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH
Copyright © 2022 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. (02/22) EM-US-102145
Please see accompanying JARDIANCE Prescribing Information and JARDIANCE Medication Guide
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Nutrition Tips for Primary Care: Strategies from a Dietician Beyond the Basics
Bethany Doerfler, MS, RDN
Nutrition research and recommendations are rapidly changing. Fill your toolbox with behavioral and food-driven action plans to answer your patients' toughest nutrition and lifestyle issues. Updated recommendations for nutrition advice for IBS, intermittent fasting, popular diets, food intolerances, and more will be answered.
Senior Clinical Research Dietitian, Northwestern University, Feinberg School of Medicine, Adjunct Faculty, Marciella School of Nursing, Loyola University, Chicago, IL
Cardiovascular Disease and Women
Karol E. Watson, MD, PhD
Heart disease is the leading cause of death for women, and the pathophysiology, prevention strategies, screening, and treatments are often different from men. This session will discuss differences and similarities in heart disease between women and men and offer recommendations for prevention, evaluation, and treatment.
Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventive Cardiology, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA
A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data
Kimberly Orleck, PA
Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.
Atlanta Gastroenterology Associates
Sponsored by AbbVie Inc.
Fatty Liver Manifestation of the Metabolic Syndrome: Diagnosis, Natural History, and Treatment
Sammy Saab, MD, MPH, AGAF
Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.
Professor, Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, Head, Outcomes Research in Hepatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Dermatology A-Z: A Refresher for Primary Care
Daniela Kroshinsky, MD, MPH
This session will provide an update on common skin disorders including diagnosis and management of papulosquamous disorders, medication reactions, skin infections, and melanocytic lesions.
Associate Professor of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
“It’s the Little Things”: A Tale of Two Patients
Abena Osei-Wusu, MD, FACC, FSCAI | Mark Stampehl, MD, FACC, FHFSA
This video follows two patients on their cardiovascular disease journeys. Risk factors leading to the development and progression of atherosclerotic cardiovascular disease and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted.
Medical Director, Atherosclerosis, Cardiovascular, Renal & Metabolic Medical Unit, Novartis Pharmaceuticals Corporation
Executive Medical Director, Cardiovascular, Renal & Metabolic Medical Unit, Novartis Pharmaceuticals Corporation
Sponsored by Novartis Pharmaceuticals Corporation